Skip to content
healthcare.dev

Carbamazepine

NDC 50268-171, Carbamazepine, capsule, extended release, from AvPAK.

Product NDC
50268-171
Status
Listed
Labeler
AvPAK
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078986
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE200 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
50268-171-135026801711330 BLISTER PACK in 1 BOX (50268-171-13) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (50268-171-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ceb84aa4-2041-6e6e-e053-2995a90a0f24
  • NADAC price for package 50268017113

    GET /v1/drugs/nadac/50268017113

Use it

Look up 50268-171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.